Implementation of emergency department screening to impact rising syphilis rates in vulnerable populations

实施急诊科筛查以影响弱势群体不断上升的梅毒发病率

基本信息

  • 批准号:
    10670922
  • 负责人:
  • 金额:
    $ 18.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-07-25 至 2026-06-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Syphilis rates in the U.S. have been increasing steadily since 2001, with more than 130,000 new cases reported in 2019. Left untreated, syphilis can lead to neurologic, psychiatric, cardiovascular, and other severe medical consequences, in addition to stillbirth or devastating congenital defects in infants of infected mothers. Syphilis disproportionately affects minority populations, in particular Black and Hispanic communities. Rates of congenital syphilis are also rising rapidly, paralleling an increase in rates among young women. Detection of syphilis among women of childbearing potential will be key to eliminating congenital syphilis. Current screening strategies rely on identification of symptoms or risk factors in patients attending ambulatory care, but this may result in many missed diagnoses, as syphilis can remain asymptomatic for years, patients may not perceive themselves as at risk or report relevant risk factors, and the patients most vulnerable to syphilis may also be the least likely to attend routine outpatient care. To address this issue, I created and pilot-tested an approach for universal syphilis screening in the emergency department (ED), where many vulnerable patients preferentially seek medical care. My long-term goal is to scale up this program and create a robust model that can eventually be scaled-out to other urban EDs in Chicago and across the country, and to accomplish this I will need additional data and training in implementation science. In this career development proposal, I will evaluate and improve my screening model and prepare for expansion to additional sites using implementation science strategies, informed by the Exploration, Preparation, Implementation, Sustainment (EPIS) model, a robust determinants framework in implementation science. The Exploration phase will consist of an assessment of the readiness of key stakeholders outside our institution to adopt a similar screening model. The Preparation phase will be developed concurrently to include an evaluation of the contextual factors that have contributed to successes and failures of the existing screening program, including specifically the costs associated with such programs. The Implementation and Sustainment phases represent future directions as the model is improved and sustained over time at our hospital and ultimately implemented at other institutions as part of future R01-level studies. The knowledge developed as a result of this proposal will fill important gaps in how to implement successful, context- specific ED screening programs with effective linkage to care plans, which may serve not only to increase syphilis diagnosis and treatment, but also could be applied to screening for other diseases affecting the most vulnerable populations. This K23 award will provide advanced training in implementation science, mixed methods research, and healthcare economics that will build on my background in public health and epidemiology. I will bring my research and clinical experience together with that of an experienced mentorship team to develop the skills necessary to become an independent investigator and eventually a leader in ED screening methodology and implementation science.
项目摘要 自2001年以来,美国的梅毒发病率一直在稳步上升,报告的新病例超过13万例。 2019年如果不及时治疗,梅毒可导致神经系统,精神,心血管和其他严重的医疗问题。 此外,受感染母亲的婴儿还会出现死产或严重的先天性缺陷。梅毒 这对少数民族人口,特别是黑人和西班牙裔社区的影响尤为严重。先天性 梅毒发病率也在迅速上升,与此同时,年轻妇女的发病率也在上升。梅毒的检测 有生育能力的妇女将是消除先天性梅毒的关键。目前的筛查策略依赖于 对识别参加门诊护理的患者的症状或风险因素,但这可能会导致许多 漏诊,因为梅毒可以保持无症状多年,患者可能不认为自己是在 风险或报告相关的风险因素,最容易感染梅毒的患者也可能是最不可能感染梅毒的患者。 参加常规门诊护理。为了解决这个问题,我创建并试点测试了一种普遍梅毒的方法 在急诊科(艾德)进行筛查,许多脆弱的患者优先寻求医疗护理。 我的长期目标是扩大这个项目,并创建一个强大的模型,最终可以扩展到 芝加哥和全国其他城市的急诊科医生,为了完成这项工作,我需要额外的数据和培训 in implementation实现science科学.在这份职业发展建议书中,我将评估和改进我的筛选模型 并利用实施科学战略,准备扩展到其他地点, 探索,准备,实施,维持(EPIS)模型,一个强大的决定因素框架, 执行科学。探索阶段将包括评估关键的 我们的机构以外的利益相关者采用类似的筛选模式。将开发准备阶段 同时包括对促成成功和失败的背景因素的评价, 现有的筛查方案,特别包括与这些方案有关的费用。的 随着模型的改进和维持,实施和维持阶段代表了未来的方向 随着时间的推移,在我们医院,并最终在其他机构实施,作为未来R01水平研究的一部分。的 由于这项建议而发展起来的知识将填补如何成功地实施, 具体的艾德筛查计划与护理计划有效联系,这不仅可以增加梅毒 诊断和治疗,但也可以适用于筛查影响最脆弱的其他疾病 人口。这个K23奖将提供实施科学,混合方法研究, 以及医疗经济学,这将建立在我的公共卫生和流行病学背景之上。我会带上我的 研究和临床经验,以及经验丰富的导师团队,以发展技能 有必要成为一名独立的研究者,并最终成为艾德筛查方法的领导者, 执行科学。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Trends in STI testing and diagnosis rates during the COVID-19 pandemic at a large urban tertiary care center, and the role of the emergency department in STI care.
  • DOI:
    10.3389/frph.2023.1082429
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Stanford, Kimberly A;Mason, Joseph A;Friedman, Eleanor E
  • 通讯作者:
    Friedman, Eleanor E
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kimberly Stanford其他文献

Kimberly Stanford的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kimberly Stanford', 18)}}的其他基金

Implementation of emergency department screening to impact rising syphilis rates in vulnerable populations
实施急诊科筛查以影响弱势群体不断上升的梅毒发病率
  • 批准号:
    10525502
  • 财政年份:
    2022
  • 资助金额:
    $ 18.6万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 18.6万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 18.6万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.6万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.6万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 18.6万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.6万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 18.6万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 18.6万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 18.6万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.6万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了